Media stories about Moelis & (NYSE:MC) have been trending somewhat positive this week, Accern Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Moelis & earned a coverage optimism score of 0.11 on Accern’s scale. Accern also assigned news articles about the asset manager an impact score of 45.0332165702716 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Here are some of the media stories that may have effected Accern Sentiment’s rankings:

Moelis & (MC) opened at 42.20 on Wednesday. The stock has a market cap of $1.16 billion, a price-to-earnings ratio of 19.52 and a beta of 1.90. The firm’s 50 day moving average price is $40.77 and its 200-day moving average price is $38.80. Moelis & has a 1-year low of $23.60 and a 1-year high of $44.85.

Moelis & (NYSE:MC) last announced its earnings results on Monday, July 24th. The asset manager reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.15. Moelis & had a net margin of 8.50% and a return on equity of 52.98%. The business had revenue of $172.10 million during the quarter, compared to the consensus estimate of $156.85 million. During the same quarter in the prior year, the firm earned $0.35 earnings per share. The business’s quarterly revenue was up 30.7% compared to the same quarter last year. On average, equities analysts anticipate that Moelis & will post $2.23 earnings per share for the current year.

A number of brokerages have commented on MC. Zacks Investment Research cut Moelis & from a “buy” rating to a “hold” rating in a research report on Wednesday, October 4th. BidaskClub raised Moelis & from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, July 12th. JMP Securities lifted their price target on Moelis & from $42.00 to $44.00 and gave the stock a “market outperform” rating in a research report on Tuesday, July 25th. Morgan Stanley lifted their price target on Moelis & from $39.00 to $45.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 25th. Finally, UBS AG reaffirmed a “neutral” rating and set a $42.00 price target (up previously from $40.00) on shares of Moelis & in a research report on Tuesday, July 25th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $39.22.

WARNING: This news story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another domain, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The legal version of this news story can be viewed at

Moelis & Company Profile

Moelis & Company is an investment banking advisory company. The Company provides strategic and financial advice to a client base, including corporations, governments and financial sponsors. The Company offers financial advisory services across various industry sectors. It advices its clients on decisions, including mergers and acquisitions (M&A), recapitalizations and restructurings, and other corporate finance matters.

Insider Buying and Selling by Quarter for Moelis & (NYSE:MC)

Receive News & Stock Ratings for Moelis & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moelis & Company and related stocks with our FREE daily email newsletter.